Bellevue Life Sciences Acquisition Corp. (BLAC)

10.80 +0.06 (+0.56%) As of 04:00PM EDT. Market open.

Bellevue Life Sciences Acquisition Corp.

10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
United States
425 635 7700
https://www.bellevuespac.com

Sector(s): Financial Services
Industry: Shell Companies
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Kuk Hyoun Hwang	CEO & Director	N/A	N/A	1976
Mr. David Jin Yoo	Chief Financial Officer	N/A	N/A	1974

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Corporate Governance

Bellevue Life Sciences Acquisition Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.